Perioperative medicine & outcomes

Effect of S-Ketamine on Postoperative Delirium in Elderly Patients Undergoing Arthroplasty: A Randomized Controlled Trial

AnesthesiologyPublished Randomised controlled trial

Primary resultResult — go to the resultAdjusted odds ratio 0.29 95% CI 0.14–0.63

Authors' conclusion

S-ketamine can reduce risk of POD in elderly patients undergoing total hip or knee arthroplasty under neuraxial anesthesia.

Study context

Population
Elderly patients undergoing total hip or knee arthroplasty under neuraxial anesthesia, high-volume arthroplasty referral center
Participants
372 patients
Comparison
S-ketamine vs normal saline placebo under neuraxial anaesthesia
  • S-ketaminen = 186
  • Placebon = 186reference
Primary endpoint
Risk of POD
Follow-up
Within 3 days after surgery
Methodological detailsplacebo-controlled, single-centre, Enrolled November 2023 to October 2024; in-person follow-up from admission to 3 days after surgery
  • Placebo-controlled
  • Single-centre
  • Enrolled November 2023 to October 2024; in-person follow-up from admission to 3 days after surgery

Primary result

As reported in the abstract

Adjusted odds ratio

0.29

95% CI 0.14–0.63

P = 0.002

Events by treatment group

S-ketamine vs Placebo
aOR 0.29 (95% CI 0.14–0.63); P = 0.002

Secondary outcomes

Pain during exercise and physical therapy; rescue analgesia use · postoperative delirium (POD) 1

Significantly less pain during exercise and physical therapy and lower incidence of rescue analgesia use with S-ketamine vs placebo

Safety

Incidence of hallucinations, dizziness and nightmares higher with S-ketamine vs placebo
Other complications low in both groups, no statistically significant differences

Original publication

Effect of S-Ketamine on Postoperative Delirium in Elderly Patients Undergoing Arthroplasty: A Randomized Controlled Trial. Anesthesiology. Published 14 October 2025. doi:10.1097/aln.0000000000005800

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.